Agentix Corp (AGTX)

OTC Markets
0.15
0.00(0.00%)
  • Volume:
    4,000
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.15 - 0.15

AGTX Overview

Prev. Close
0.16
Day's Range
0.15-0.15
Revenue
-
Open
0.15
52 wk Range
0.15-1.24
EPS
-0.07
Volume
4,000
Market Cap
5.84M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,219
P/E Ratio
-
Beta
-
1-Year Change
-86.61%
Shares Outstanding
38,916,951
Next Earnings Date
-
What is your sentiment on Agentix?
or
Market is currently closed. Voting is open during market hours.

Agentix Corp Company Profile

Agentix Corp Company Profile

Employees
0

Agentix Corp. is a biotechnology company. The Company is focused on the development of synthetic agonists, inverse agonists, and antagonists, which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein-coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. It has licensed patented, synthetically derived, small molecule therapeutic candidates targeting the endocannabinoid GPCRs (CB1/CB2) for the treatment of metabolic syndrome and peripheral inflammation. The Company is also engaged in clinical trials of its product line. Its wholly owned subsidiary is GSL Healthcare, Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell